LBC's role in lower Scottish cervical screening rates
This article was originally published in Clinica
Executive Summary
The introduction of liquid-based cytology (LBC) in Scotland's cervical screening programme has delivered notable improvements in testing quality and rapidity, according to statistics for the first full year of LBC provision, released yesterday. The resulting reduction in repeat tests explains the significant fall in the number of smears processed, according to the Scottish Executive, but a closer look at the statistics also reveals a marginal fall in uptake rates.
You may also be interested in...
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.